Minnesota Oncology Welcomes New Radiation Oncologist

Minnesota Oncology is pleased to announce the association of Stephanie Krejcarek Childs, M.D. with the practice of Radiation Oncology at the Maplewood Cancer Center.

Dr. Childs holds a Bachelor of Science degree from Brown University and received her medical degree from Harvard Medical School, Boston, MA. After an internship at Brigham and Women's Hospital in Boston, Dr. Childs completed a residency in the Harvard Radiation Oncology Residency Program. 

Among her honors, Dr. Childs was the recipient of a Fulbright Fellowship from the Fulbright Foundation of Sweden.

She holds Diplomat Board Certification from the American Board of Radiology.  

Dr. Childs most recently served as Assistant Professor of Radiation Oncology at the Mayo College School of Medicine and as Senior Associate Consultant in the Mayo Clinic Department of Radiation Oncology. 

She has co-authored a number of peer reviewed articles and abstracts in publications such as the International Journal of Radiation Oncology; the Journal of Clinical Oncology; and Neuro Oncology.

Appointments can be scheduled with Dr. Childs at the Maplewood Cancer Center by calling (651) 779-7978.

Share

Categories

Tags

Recent Posts

#
May 28, 2025

This is the story about the origin of the Angel Foundation. Minnesota Oncology has long supported the Angel Foundation through sponsorships, employee-driven fundraisers, volunteerism, and payroll deduction. But many may not know why our two organizations are so close and how the foundation started.

#
May 19, 2025

Exposure to bacteria may contribute to rising rates of colorectal cancer in young adults. Colorectal cancer has moved from being the fourth leading of cause of cancer related death in both men and women under the age of 50 two decades ago to being number one in men and second in women.

#
May 15, 2025

Spiritual care is a type of support within healthcare that addresses a person's spiritual, existential, and emotional needs, often in times of illness or crisis.